Cosmos Health Inc. (COSM)
Cosmos Health Inc. (COSM) Stock Price, Analysis & Data
No data available
| Bid | 0.14 |
| Market Cap | 11.98M |
| Revenue (ttm) | 69.49M |
| Net Income (ttm) | -21.13M |
| Beta | 4.17 |
| EPS (ttm) | -0.66 |
| PE Ratio (ttm) | n/a |
| Forward PE | 2.76 |
| P/B (ttm) | 0.43 |
| P/S (ttm) | 0.17 |
| Earnings Date | n/a |
| Ask | 0.23 |
| Volume | 4,606,668 |
| Avg. Volume (20D) | 9,882,916 |
| Open | 0.19 |
| Previous Close | 0.21 |
| Day's Range | 0.18 - 0.20 |
| 52-Week Range | 0.16 - 1.32 |
| Analyst | n/a |
| Price Target | 4.5 (2268.42%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About COSM
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravasta...
Financial Performance
In 2025, Cosmos Health's revenue was 65.27M, an increase of 19.93% compared to the previous year's 54.43M. Earnings were -19.14M, an increase of 18.3%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for COSM stock is "null". The 12-month stock price forecast is 4.5, which is upside of 2268.42% from the latest price.
Stock Forecasts
